Cleft lip with or without palate (CLP) and isolated cleft palate (CP) are common human developmental malformations with a complex etiology that reflects a failure of normal facial development. VAX1 encodes a homeobox-containing transcription factor identified as a candidate gene for CLP in human populations, with targeted deletion in mice associated with multiple anomalies, including disruption of the visual apparatus and basal forebrain, lobar holoprosencephaly, and CP. We have investigated Vax1 function during murine palatogenesis but found no evidence for a direct role in this process. Vax1 is not expressed in the developing palate and mutant palatal shelves elevate above the tongue, demonstrating morphology and proliferation indices indistinguishable from wild type. However, mutant mice did have a large midline cavity originating from the embryonic forebrain situated beneath the floor of the hypothalamus and extending through the nasal cavity to expand this region and prevent approximation of the palatal shelves. Interestingly, despite strong expression of Vax1 in ectoderm of the medial nasal processes, the upper lip remained intact in mutant mice. We found further evidence of disrupted craniofacial morphology in Vax1 mutants, including truncation of the midface associated with reduced cell proliferation in forebrain neuroectoderm and frontonasal mesenchyme. Sonic hedgehog (Shh) signal transduction was downregulated in the mutant forebrain, consistent with a role for Vax1 in mediating transduction of this pathway. However, Shh was also reduced in this region, suggestive of a Shh-Vax1 feedback loop during early development of the forebrain and a likely mechanism for the underlying lobar holoprosencephaly. Despite significant associations between VAX1 and human forms of CLP, we find no evidence of a direct role for this transcription factor in development of this region in a mutant mouse model.
Introduction
Cleft lip with or without the palate (CLP) or isolated clefts of the palate (CP) are relatively common human congenital malformations seen with a prevalence ranging from 1:500 to 2,000 live births, depending upon racial background. The etiological basis of these disorders is complex but reflects a failure of normal facial development mediated through genetic and environmental factors (Dixon et al. 2011) . A number of independent studies have found associations between the homeobox gene VAX1 and CLP in human populations (Slavotinek et al. 2012; Butali et al. 2013; de Aquino et al. 2013; Zawislak et al. 2014; de Araujo et al. 2016; Gowans et al. 2016; Peng et al. 2016; Wang et al. 2016; Wen and Lu 2016) and Vax genes act downstream of sonic hedgehog (Shh) (Hallonet et al. 1999; Takeuchi et al. 2003; Kim and Lemke 2006; Zhao et al. 2010 ) and as both Fgf and Wnt antagonists in a number of developmental contexts (Bharti et al. 2011; Vacik et al. 2011) . Vax1 is first expressed in the early central nervous system (CNS) (Hallonet et al. 1998; Bertuzzi et al. 1999; Taglialatela et al. 2004) , and targeted disruption in mice produces multiple defects in the visual apparatus, including coloboma and absence of the optic chiasma, accompanying growth defects in the medioventral CNS, altered axonal guidance, and duplication of the pituitary gland (Bertuzzi et al. 1999; Hallonet et al. 1999; Taglialatela et al. 2004; Bharti et al. 2011) . Significantly, Vax1 mutant mice also have lobar holoprosencephaly (HPE) and CP, although the molecular basis of these defects has not been investigated (Bertuzzi et al. 1999; Hallonet et al. 1999) .
HPE is a heterogeneous and complex developmental anomaly associated with incomplete division of the embryonic forebrain and classified as alobar, semilobar, or lobar, depending upon the amount of cleavage within the telencephalon. A key feature of HPE is aberrant facial development, which can manifest as frank cyclopia or in association with other facial defects, including hypotelorism, single nostril, single median maxillary central incisor (SMMCI), and CLP (Geng and Oliver 2009 ). HPE has marked clinical variation, with notoriously poor genotypic-phenotypic correlation and wide-ranging intrafamilial variability in humans (Ming and Muenke 2002) . Moreover, increasing evidence from mouse models has demonstrated the significance of multiple genetic and environmental factors that can influence phenotype (Heyne et al. 2016; Hong and Krauss 2012) .
Here we describe in detail the craniofacial defects associated with loss of Vax1 in the mouse and further investigate the role of Vax1 during palatogenesis. Vax1 was expressed in ectoderm of the medial nasal processes within the developing facial region, but transcripts were not identifiable in the secondary palate. Although loss of Vax1 is associated with a fully penetrant CP, the upper lip remains intact in mutant mice. We provide evidence to suggest that CP occurs secondary to disruption within the CNS rather than a direct requirement for Vax1 during palatogenesis. We further identify reduced Shh signal transduction in the early ventral forebrain and reduced levels of proliferation in neuroectoderm of this region in mutant mice. Interestingly, loss of Vax1 in a background of reduced Shh activity through generation of Vax1; Gas1 compound mutant mice did not worsen the cleft phenotype, although the SMMCI seen in association with loss of single alleles reverted to complete incisor agenesis in the compound mutants.
Materials and Methods

Generation of Vax1 and Gas1 Single and Compound Mutant Mice
All procedures were carried out in accordance with the UK Animals (Scientific Procedures) Act (1986) and subject to the approved protocols at King's College London. This study conforms with ARRIVE guidelines. Vax1 and Gas1 mice were housed in a Biological Services Unit, generated and maintained on a 129sv/C57BL6 background, and genotyped as previously described (Hallonet et al. 1999; Lee et al. 2001) . For Vax1; Gas1 mice, both mutant alleles contain a LacZ and, therefore, genotyping involving 2 reactions. For the first, the forward primer was constructed to align against the promoter region of Gas1 (CCGGAGAGTGGAGAAAGGAG); the reverse primer aligned against the LacZ cassette (CCCCTGAG CATGATCTTCCA) to produce a 392-bp polymerase chain reaction (PCR) product. For the second, a 350-bp fragment of the wild-type (WT) Gas1 allele deleted in the mutant was amplified using the forward primer (ATCTCGGCGCTTATC CAGCTCAAC) and reverse primer (CATCGCACACGCAGTC GTTGAGCA). Timed matings were set up such that noon of the day on which vaginal plugs were detected was considered embryonic day (E) 0.5. Pregnant females were euthanized with cervical dislocation. For all experiments, a minimum number of 3 WT and 3 mutant mice were compared.
Histology, Skeletal Analysis, and In Situ Hybridization
Histological analysis, differential staining of bone and cartilage, and radioactive and digoxigenin-section in situ hybridization were conducted as previously described (Seppala et al. 2007; Oommen et al. 2012 ).
Proliferation, Apoptosis, and Craniofacial Dimensional Assays
Bromodeoxyuridine (BrdU) labeling for cell proliferation assays was carried out on histological sections using a Zymed BrdU Labeling and Detection Kit (Invitrogen) according to manufacturer instructions. Mouse embryos were labeled with BrdU via intraperitoneal injection into pregnant females (5 mg/100 g body weight) 2 h prior to sacrifice. Embryos were fixed in 4% paraformaldehyde (PFA) at 4°C overnight, dehydrated in ethanol, embedded in paraffin wax, and sectioned at 7 µm. The percentage of BrdU-positive cells was calculated.
Immunohistochemical detection of apoptotic cell death was carried out on histological sections using terminal deoxynucleotidyl transferase-mediated deoxyuridine triphosphate nick end labeling (TUNEL). TUNEL was carried out using an APOPTag Plus Fluorescein In Situ Apoptosis Detection Kit (Chemicon) according to manufacturer instructions.
Craniofacial dimensions were measured on histological sections using lines constructed from specific anatomical points (Schambra, 2008) . All cell counting and linear measurement was conducted by 1 researcher blinded to experimental group on 2 separate occasions 1 wk apart and the mean value calculated.
Quantitative Reverse Transcription PCR Analysis
Quantitative reverse transcription PCR (qRT-PCR) analysis of Shh, Ptch1, and Nkx2.1 expression was performed on E10.5 WT and Vax1 -/embryo heads. Tissue was carefully dissected from the ventral forebrain and facial area and immediately transferred into Trizol. Complementary DNA (cDNA) was synthesized from total RNA and quantitative PCR (qPCR) performed using SYBR Green PCR Master Mix in an ABI Prism 7900 HT cycler (Applied Biosystems). A standard curve method of quantitation was used to calculate expression of target genes relative to the housekeeping gene β-actin. Four serial dilutions of cDNA (1:4) were made for the calibration curve, and trend lines were drawn using Ct values versus log of dilutions for each target gene and β-actin run in triplicate with a correlation coefficient (R 2 > 0.99). Relative expressions were calculated using line equations derived from calibration curves and obtaining ratios of target gene to β-actin. For each gene, experiments were run at least 3 times using cDNA obtained from 3 independent RNA purifications. Data were analyzed as previously described (Livak and Schmittgen 2001) .
Results
Vax1 Mutant Mice Have Multiple Craniofacial Anomalies
We investigated the craniofacial phenotype of Vax1 -/embryos from E12.5 to E17.5 using skeletal preparation and standard histology (n = 4 for all stages) ( Fig. 1A -D, E-V, respectively). Consistent with previous reports (Bertuzzi et al. 1999; Hallonet et al. 1999) , Vax1 -/embryos exhibited lobar HPE associated with narrowing in the maxillary incisor region and SMMCI, but the upper lip remained intact (Appendix Fig. 1 ). In general, the mutant skull was slightly smaller than WT with obvious retrusion in the maxillary region. The dermatocranium was normal, but multiple defects associated with neurocranial and splanchnocranial elements of the chondrocranium were identified. These predominated along the ventral midline and varied in severity between mutants ( Fig. 1D , i-iii). Within the nasal cavity, the septum was either hypoplastic or absent, with accompanying hypoplasia of the paraseptal cartilages and vomer. There was CP occurring with complete penetrance and associated with defects in the paired maxillary and palatine bones. Specifically, a variable circular midline defect affected the body of the premaxilla, and there was hypoplasia of the palatal shelves. The palatal processes of the maxilla In addition, the presence of only a single midline maxillary central incisor (red arrow), absence of the nasal septum (green arrow), cleft palate (red asterisk), and fenestrations in the region of the spheno-occipital synchondrosis (yellow arrow) were also identifiable in the mutant compared to WT (note that the squamosal and frontal bones have been partially removed in the mutant skull). (C, D) Highlight of the ventral maxillary region in WT (C) and mutant skulls (D) demonstrating a spectrum of increasing severity associated with the midline anomalies seen in the mutant (indicated in Di, ii, and iii and by the elongated black arrow)-in particular, the size of the premaxillary midline fenestration (red arrows) and hypoplasia of the palatal processes of the premaxilla (orange arrows) and maxilla (pale blue arrows). In addition, the body of the palatine bone was also hypoplastic and lacked palatal processes (dark green arrows), revealing a severe disruption and increasing hypoplasia associated with the presphenoid (violet arrows). Fenestrations were also present in association with the basisphenoid (yellow arrows). (E-V) E12.5 to E15.5 frontal sections of the anterior, middle, and posterior palatal regions stained with hematoxylin and eosin. E12.5 WT (E-G) and Vax1 -/-(H-J) demonstrating constriction of the frontonasal region (black asterisk in H) and normal morphology of the palatal shelves in the mutant. E13.5 WT (K-M) and Vax1 -/-(N-P) demonstrating normal palatal shelf morphology in the mutant. E14.5 WT (Q-S) and Vax1 -/-(T-V) demonstrating the presence of cleft palate in the mutant and a large midline extension of the central nervous system within the nasal cavity (green asterisk in T) separated from the oral cavity by a layer of neuroectoderm (black arrow in U). Glossary for Fig. 1 and Appendix Fig. 1 . ab, alveolar bone of mandible; agp, angular process of mandible; als, alisphenoid; bb, basal bone of mandible; bo, basioccipital; bps, body of presphenoid; bs, basisphenoid; cbi, crus brevis of incus; cdp, condylar process of mandible; cli, crus longus of incus; cna, cupola nasi anterior; crp, coronoid process of mandible; c1, first cervical vertebra; eo, exoccipital; fpmx, frontal process of maxilla; fr, frontal; go, gonial; in, incus; ip, interparietal; jg, jugal; li, lower incisor; lo, lamina obturans; ma, mandible; MC, Meckel's cartilage; mm, manubrium of malleus; mpps, medial process of presphenoid; mx, maxilla; na, nasal; ns, nasal septum; pbm, processus brevis of malleus; pca, pars canalicularis; pco, pars cochlearis; pl, palatine; plpps, posterior lateral process of presphenoid; pmx, premaxilla; ppmx, palatine process of maxilla; pppl, palatine process of palatine; pppx, palatal process of premaxilla; pr, parietal; ps, preshenoid; ptg, pterygoid; so, supraoccipital; sp, styloid process; sq, squamosal; st, stapes; tr, tympanic ring; ui, upper incisor; vo, vomer; zpsq, zygomatic process squamosal. This figure is available in color online.
were also hypoplastic and the palatine bone severely disrupted, lacking palatal processes in many cases and exposing the underlying presphenoid bone, which itself lacked medial processes and demonstrated a variable level of hypoplasia within the body, the entire bone being essentially absent in some mutants. The aural and mandibular regions were normal (Appendix Fig. 2) .
The CP phenotype was identifiable in all mutants, communicating with the nasal cavity anteriorly and associated with palatal shelves that elevated above the tongue but failed to approximate toward the midline (Fig. 1E-V) . Gross architecture of the mutant palatal shelves was normal, with no evidence of disrupted growth or development associated with these structures. However, the nasal septum was absent and the nasomaxillary region disrupted by a large midline cavity originating from the forebrain and extending beneath the floor of the hypothalamus (Fig. 1T, green asterisk) . This structure separated the paired vomeronasal organs (VNOs) and was demarcated from the oral cavity by only a thin region of neuroectoderm in more posterior regions (Fig. 1U, black arrow) . Significantly, paired VNOs were present and situated medially adjacent to the widened nasal cavity. This suggested that the CP might be secondary to associated defects within the CNS rather than a direct effect of Vax1 function within the palate.
Vax1 Does Not Play a Direct Role in Murine Palatogenesis
To further understand the role of Vax1 during palatogenesis, we analyzed expression in the developing palate from E10.5 to E14.5 using in situ hybridization. Vax1 transcripts were identified in bilateralrestricted regions of ectoderm in the medial nasal processes at E10.5, with additional weak expression in midline ectoderm of the frontonasal process (n = 4) ( Fig. 2A-C) . The domains of expression within the medial nasal processes persisted during subsequent growth and fusion with the lateral nasal processes to remain in ectoderm of the presumptive budding VNO between E11.5 and E12.5 (n = 4 and 6, respectively) ( Fig. 2D-F ) and, ultimately, persist in the VNO itself (data not shown). Significantly, Vax1 transcripts were not identifiable in either epithelial or mesenchymal regions of the secondary palate from E12.5 to E14.5 (n = 3) ( Fig. 2G-J) , a finding that was further verified with RT-PCR (Appendix Fig. 3 ). However, given the failure of the palatal shelves to approximate, we could not definitively rule out a secondary growth defect in the mutant and therefore analyzed proliferation in these shelves at E13.5 (Fig. 3A-D ). There were no significant differences in epithelial or mesenchymal proliferation indices between WT and Vax1 -/at E13.5 or in linear dimensions of the shelves at E14.5 (data not shown). Collectively, these findings suggest that Vax1 does not play a direct role in development of the secondary palate and that the associated craniofacial defects contributed to the observed CP. 
Disrupted Proliferation in the Early Forebrain in the Absence of Vax1 Function
The evidence to suggest that Vax1 does not play a direct role in mediating palatogenesis prompted us to investigate gross anatomy of the early craniofacial region in WT and Vax1 -/mice at E11.5 (n = 4). Interestingly, we found significant truncation in the ventral forebrain region and midface of the mutant compared to WT ( Fig. 4A-C) . We next analyzed cell proliferation and apoptosis in this region at the same stage. Consistent with the reduced linear dimensions in these midline regions, we found significantly reduced proliferation in neuroectoderm of the ventral forebrain and mesenchyme within the frontonasal region in the mutant when compared to WT (Fig. 4D-F) . However, there were no differences observed in levels of cell death (data not shown). a significant difference in percentage proliferating cells between WT and mutant embryos at all locations measured. A total of 3 WT and 3 Vax1 -/mice were analyzed. Student's t tests were performed to assess whether the means between groups were statistically different from each other. P values of less than 0.05 were considered statistically significant. Data are represented as mean and standard deviation (*P < 0.05; **P < 0.001).
Reduced Shh Signaling in the Early Craniofacial Region in the Absence of Vax1 Function
There is evidence that Vax1 lies downstream of Hedgehog signaling in several developmental models (Hallonet et al. 1999; Take-uchi et al. 2003; Kim and Lemke 2006; Zhao et al. 2010) , and Vax1 transcripts are directly adjacent to Shh in the early ventral forebrain and medial nasal process (Appendix Fig. 4) . Given the presence of lobar HPE in Vax1 -/embryos associated with abnormal growth in the ventral forebrain and facial midline, we investigated Hedgehog signaling in these regions at E10.5 (n = 7 for each group) ( Fig. 5A-C , G-I, D-F, J-L). There was evidence of a reduced Shh transcriptional domain in the midline ventral forebrain of Vax1 -/embryos compared to WT and an accompanying reduction of Ptch1 in ventral neuroectoderm and facial mesenchyme. We also investigated expression of the direct Shh target Nkx2.1 (Pabst et al. 2000; Gulacsi and Anderson 2006) and found reduced expression ( Fig.  5M -O, P-R). A more quantitative approach was also used through qRT-PCR following RNA extraction from dissected E10.5 WT and Vax1 -/-(n = 3 for both groups) embryonic heads (Appendix Fig.  5 ). Messenger RNA (mRNA) levels of Shh and Ptch1 were significantly reduced in Vax1 mutants in comparison to WT.
Collectively, these data suggest that the craniofacial phenotype associated with loss of Vax1 function is directly related to reduced Shh signal transduction in the craniofacial region from E10.5.
Loss of Vax1 Function in the Absence of Gas1
It has been suggested that numerous genetic and environmental factors may influence phenotype in HPE and in some circumstances may be due to mutation in multiple alleles (Ming and Muenke 2002) . Gas1 encodes a Shh coreceptor, with loss of function associated with reduced Shh signaling in the midface and microform HPE (Seppala et al. 2007; Seppala et al. 2014) . We therefore investigated the phenotypic consequences of a loss of Vax1 function in a Gas1 mutant background. Although the gross craniofacial features of Gas1; Vax1 compound mutant mice did not differ significantly from individual single mutants, these mice did demonstrate a complete absence of maxillary incisor development (n = 4/4), in contrast to single mutants that both have SMMCI (Hallonet et al. 1999; Seppala et al. 2007 ). Significantly, the midfacial region was normal in the compound mutants, with paired external nares and an upper lip that remained intact (Appendix Fig. 6 ).
Discussion
Vax1 -/mice have significant defects in the basal forebrain, including absence of the optic chiasma and preoptic area, medioventral growth defects, pituitary duplication, and lobar HPE. There are also facial defects, including CP and SMMCI (Bertuzzi et al. 1999; Hallonet et al. 1999; Taglialatela et al. 2004; Bharti et al. 2011) , while in human populations, VAX1 is a candidate CLP gene (Slavotinek et al. 2012; Butali et al. 2013; de Aquino et al. 2013; Zawislak et al. 2014 ; de Araujo Gowans et al. 2016; Peng et al. 2016; Wang et al. 2016; Wen and Lu 2016) , and loss-of-function mutation has been associated with microphthalmia, optic nerve hypoplasia, and absence of the corpus callosum (Slavotinek et al. 2012) . We therefore sought to further understand the role of this transcription factor during palatogenesis using the Vax1 -/mouse as a model. Significantly, the observed CP appears to be a consequence of the associated gross craniofacial defects, rather than a direct effect of Vax1 function. There was no evidence of Vax1 expression in the developing palate and no difference in the gross anatomy or levels of proliferation in the palatal shelves between WT and mutant. It is most likely that a large midline cavity within the CNS, extending from the floor of the hypothalamus through the nasal cavity to the roof of the oral cavity, was responsible for the failure of the palatal shelves to approximate in the midline. This structure has been described previously and ascribed to the presence of CP but is most likely the cause of this defect (Bertuzzi et al. 1999) .
Vax1 -/mice do have lobar HPE, and CP is a common feature of this condition, although the precise relationship between these disruptions is poorly understood. In common with other mouse models of HPE (Cole and Krauss 2003; Tenzen et al. 2006; Zhang et al. 2006; Allen et al. 2007; Martinelli and Fan 2007; Seppala et al. 2007; Zhang et al. 2011 ), Vax1 mutants have reduced Shh signaling in the early craniofacial midline, consistent with a downstream role previously identified in other developmental contexts (Hallonet et al. 1999; Take-uchi et al. 2003; Kim and Lemke 2006; Zhao et al. 2010 ). However, the reduced Shh transcription identified in the ventral forebrain also suggests a requirement for Vax1 in maintaining signaling and an important potential feedback loop in this region. Interestingly, previous investigations have not identified significant differences in Shh or Nkx2.1 expression in the telencephalic neuroectoderm of Vax1 mutants prior to E12.5 (Bertuzzi et al. 1999 ). This might be explained by the fact that these changes are subtle; however, we observed them with both in situ hybridization and qRT-PCR analysis, and the lobar HPE is fully penetrant. The presence of lobar HPE is actually rare in mouse mutants (Geng and Oliver 2009) and, with the exception of Vax1 (Bertuzzi et al. 1999) , has only previously been described in mice with loss of Shh coreceptor function (Zhang et al. 2011; Seppala et al. 2014 ).
In the mouse, Vax1 is expressed in ectoderm of the medial nasal processes and persists as these structures fuse with the lateral nasal processes at the lambdoid junction during upper lip formation. Moreover, Vax1 acts as a downstream target of Shh signaling in the medial nasal process, potentially acting to restrict Wnt pathway activity and promote cell cycle exit and epithelial fusion as lip continuity is established (Kurosaka et al. 2014) . It is therefore surprising that Vax1 -/mice do not display a cleft lip phenotype. One possible explanation is that other factors may compensate for Vax1 function in the early face, particularly during the restriction of Wnt signaling activity in the nasal processes (Kurosaka et al. 2014) . Alternatively, thresholds of activity and genetic background may influence phenotypic outcome in the mouse embryo. A closely related Vax2 gene exists, but expression is restricted to the developing eye, and targeted disruption of both genes results in conversion of the optic nerve to retina, while the upper lip remains intact (Mui et al. 2005) . Similarly, gross development of the VNO was normal in Vax1 mutants, despite transcripts being strongly expressed in this organ throughout its development. What is interesting is that reducing the levels of Shh signal activity in the midfacial region by generating abrogating Vax1 on a Gas1 mutant background did not result in CLP, although the maxillary incisor phenotype did worsen, with agenesis as opposed to SMMCI.
We have investigated the role of Vax1 during murine craniofacial development and find evidence for reduced Shh signaling in the ventral forebrain associated with reduced levels of proliferation, facial truncation, and lobar HPE. Despite expression of Vax1 in ectoderm of the medial nasal processes, the upper lip forms normally in Vax1 mutant mice. Moreover, the CP would seem to be the result of disrupted craniofacial development rather than a specific function of Vax1. In addition, Vax1; Gas1 mutant mice had a complete absence of the maxillary incisors, but upper lip formation remained normal. Despite strong evidence for VAX1 as a candidate gene for CLP in human populations, this gene is seemingly dispensable for normal upper lip development and plays an indirect role in palatogenesis in the mouse.
